Anita Dushyanth
Stock Analyst at Berenberg
(0.87)
# 2,839
Out of 4,433 analysts
5
Total ratings
60%
Success rate
-5.71%
Average return
Main Sectors:
5 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| URGN UroGen Pharma | Initiates: Buy | $20 | $13.21 | +51.40% | 1 | Apr 27, 2022 | |
| SERA Sera Prognostics | Initiates: Buy | $13 | $8.38 | +55.13% | 1 | Apr 27, 2022 | |
| RNLX Renalytix | Initiates: Buy | n/a | $0.59 | - | 1 | Jul 2, 2021 | |
| BTAI BioXcel Therapeutics | Initiates: Buy | n/a | $2.09 | - | 1 | Apr 9, 2021 | |
| PCRX Pacira BioSciences | Initiates: Buy | n/a | $31.51 | - | 1 | Apr 9, 2021 |
UroGen Pharma
Apr 27, 2022
Initiates: Buy
Price Target: $20
Current: $13.21
Upside: +51.40%
Sera Prognostics
Apr 27, 2022
Initiates: Buy
Price Target: $13
Current: $8.38
Upside: +55.13%
Renalytix
Jul 2, 2021
Initiates: Buy
Price Target: n/a
Current: $0.59
Upside: -
BioXcel Therapeutics
Apr 9, 2021
Initiates: Buy
Price Target: n/a
Current: $2.09
Upside: -
Pacira BioSciences
Apr 9, 2021
Initiates: Buy
Price Target: n/a
Current: $31.51
Upside: -